---
title: "Reviva Pharmaceuticals (RVPH.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/RVPH.US/norm.md"
symbol: "RVPH.US"
name: "Reviva Pharmaceuticals"
parent: "https://longbridge.com/zh-HK/quote/RVPH.US.md"
datetime: "2026-05-20T10:20:10.017Z"
locales:
  - [en](https://longbridge.com/en/quote/RVPH.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RVPH.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RVPH.US/norm.md)
---

# Reviva Pharmaceuticals (RVPH.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.4600 | -0.5670 | -1.10 | -2.43 | -2.64 |
| ROE | -98.01% | -204.14% | -784.39% | 984.49% | 1410.92% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -3.20M | -3.37M | -4.01M | -6.05M | -6.43M |
| 營業利潤 | -3.27M | -3.56M | -4.03M | -6.07M | -6.54M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 23.56M | 15.92M | 14.33M | 11.63M | 7.08M |
| 權益乘數 | 1.35 | 1.84 | 3.15 | -25.34 | -1.59 |
| 每股凈資產 | 1.36 | 1.47 | 0.9445 | -0.1350 | -1.91 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 22.19M | 14.44M | 13.18M | 10.36M | 5.29M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | - | - | - | - | - |
| 凈債務 | -21.96M | -14.03M | -13.18M | -10.25M | -5.07M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -3.80M | -5.80M | -5.59M | -5.01M | -8.19M |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | 11.55M | 7.05M | 8.41M | 10.09M | 7271.00 |
| 自由現金流 | -3.73M | -4.97M | -4.16M | -2.20M | -5.79M |
| 現金流充裕率 | -2164.73% | - | -4935.70% | -4513.79% | -3503.98% |
| 舉債與償債 | - | 406875.00 | - | - | - |
| 資本支出 | - | - | - | - | - |